Intracameral administration of neurotensin induces miosis in the rabbit

Daniel E. Hernandez, Kenneth B. Simmons, Robert L. Peiffer, Arthur J. Prange, Charles Nemeroff

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The present investigation was designed to evaluate the effect of selected peptides on pupillary diameter and intraocular pressure (IOP) in rabbits. Intracameral (IC) administration of neurotensin (NT) in doses of 5-100 μg produced a significant, long lasting and dose-dependent decrease in pupillary diameter without affecting IOP. NT-induced miosis appears to be relatively specific because a variety of peptides including Gn-RH, somatostatin, met-enkephalin, bombesin, leu-enkephalin or NT1-6, (a biologically inactive N-terminal fragment of NT), produced no effect on pupillary diameter; only substance P produced miosis similar to NT when tested in a dose equimolar to 30 μg of NT. In addition, peripheral (intravenous) administration of NT (100 μg/kg) was equally ineffective. Inhibition of prostaglandin synthesis with indomethacin, did not prevent subsequent NT-induced miosis. Finally, IC administration of an effective dose of NT (30 μg) did not alter the protein concentration in the aqueous humor. These results indicate that NT-induced miosis is not mediated by endogenous prostaglandins and that this effect of NT does not appear to involve disruption of the blood-aqueous barrier, suggesting that NT may play a role in regulation of pupillary diameter.

Original languageEnglish
Pages (from-to)31-40
Number of pages10
JournalNeuropeptides
Volume4
Issue number1
DOIs
StatePublished - Jan 1 1983
Externally publishedYes

Fingerprint

Miosis
Neurotensin
Rabbits
Intraocular Pressure
Prostaglandins
Blood-Aqueous Barrier
Leucine Enkephalin
Bombesin
Methionine Enkephalin
Peptides
Aqueous Humor
Substance P
Somatostatin
Gonadotropin-Releasing Hormone
Indomethacin
Intravenous Administration
Blood

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Clinical Neurology
  • Neuroscience(all)
  • Cellular and Molecular Neuroscience

Cite this

Intracameral administration of neurotensin induces miosis in the rabbit. / Hernandez, Daniel E.; Simmons, Kenneth B.; Peiffer, Robert L.; Prange, Arthur J.; Nemeroff, Charles.

In: Neuropeptides, Vol. 4, No. 1, 01.01.1983, p. 31-40.

Research output: Contribution to journalArticle

Hernandez, Daniel E. ; Simmons, Kenneth B. ; Peiffer, Robert L. ; Prange, Arthur J. ; Nemeroff, Charles. / Intracameral administration of neurotensin induces miosis in the rabbit. In: Neuropeptides. 1983 ; Vol. 4, No. 1. pp. 31-40.
@article{3bf3836293c84915bf0d6fc1557054e8,
title = "Intracameral administration of neurotensin induces miosis in the rabbit",
abstract = "The present investigation was designed to evaluate the effect of selected peptides on pupillary diameter and intraocular pressure (IOP) in rabbits. Intracameral (IC) administration of neurotensin (NT) in doses of 5-100 μg produced a significant, long lasting and dose-dependent decrease in pupillary diameter without affecting IOP. NT-induced miosis appears to be relatively specific because a variety of peptides including Gn-RH, somatostatin, met-enkephalin, bombesin, leu-enkephalin or NT1-6, (a biologically inactive N-terminal fragment of NT), produced no effect on pupillary diameter; only substance P produced miosis similar to NT when tested in a dose equimolar to 30 μg of NT. In addition, peripheral (intravenous) administration of NT (100 μg/kg) was equally ineffective. Inhibition of prostaglandin synthesis with indomethacin, did not prevent subsequent NT-induced miosis. Finally, IC administration of an effective dose of NT (30 μg) did not alter the protein concentration in the aqueous humor. These results indicate that NT-induced miosis is not mediated by endogenous prostaglandins and that this effect of NT does not appear to involve disruption of the blood-aqueous barrier, suggesting that NT may play a role in regulation of pupillary diameter.",
author = "Hernandez, {Daniel E.} and Simmons, {Kenneth B.} and Peiffer, {Robert L.} and Prange, {Arthur J.} and Charles Nemeroff",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/0143-4179(83)90005-7",
language = "English",
volume = "4",
pages = "31--40",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Intracameral administration of neurotensin induces miosis in the rabbit

AU - Hernandez, Daniel E.

AU - Simmons, Kenneth B.

AU - Peiffer, Robert L.

AU - Prange, Arthur J.

AU - Nemeroff, Charles

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The present investigation was designed to evaluate the effect of selected peptides on pupillary diameter and intraocular pressure (IOP) in rabbits. Intracameral (IC) administration of neurotensin (NT) in doses of 5-100 μg produced a significant, long lasting and dose-dependent decrease in pupillary diameter without affecting IOP. NT-induced miosis appears to be relatively specific because a variety of peptides including Gn-RH, somatostatin, met-enkephalin, bombesin, leu-enkephalin or NT1-6, (a biologically inactive N-terminal fragment of NT), produced no effect on pupillary diameter; only substance P produced miosis similar to NT when tested in a dose equimolar to 30 μg of NT. In addition, peripheral (intravenous) administration of NT (100 μg/kg) was equally ineffective. Inhibition of prostaglandin synthesis with indomethacin, did not prevent subsequent NT-induced miosis. Finally, IC administration of an effective dose of NT (30 μg) did not alter the protein concentration in the aqueous humor. These results indicate that NT-induced miosis is not mediated by endogenous prostaglandins and that this effect of NT does not appear to involve disruption of the blood-aqueous barrier, suggesting that NT may play a role in regulation of pupillary diameter.

AB - The present investigation was designed to evaluate the effect of selected peptides on pupillary diameter and intraocular pressure (IOP) in rabbits. Intracameral (IC) administration of neurotensin (NT) in doses of 5-100 μg produced a significant, long lasting and dose-dependent decrease in pupillary diameter without affecting IOP. NT-induced miosis appears to be relatively specific because a variety of peptides including Gn-RH, somatostatin, met-enkephalin, bombesin, leu-enkephalin or NT1-6, (a biologically inactive N-terminal fragment of NT), produced no effect on pupillary diameter; only substance P produced miosis similar to NT when tested in a dose equimolar to 30 μg of NT. In addition, peripheral (intravenous) administration of NT (100 μg/kg) was equally ineffective. Inhibition of prostaglandin synthesis with indomethacin, did not prevent subsequent NT-induced miosis. Finally, IC administration of an effective dose of NT (30 μg) did not alter the protein concentration in the aqueous humor. These results indicate that NT-induced miosis is not mediated by endogenous prostaglandins and that this effect of NT does not appear to involve disruption of the blood-aqueous barrier, suggesting that NT may play a role in regulation of pupillary diameter.

UR - http://www.scopus.com/inward/record.url?scp=0021080128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021080128&partnerID=8YFLogxK

U2 - 10.1016/0143-4179(83)90005-7

DO - 10.1016/0143-4179(83)90005-7

M3 - Article

C2 - 6199687

AN - SCOPUS:0021080128

VL - 4

SP - 31

EP - 40

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 1

ER -